Applications published 20 June 2007
Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration intracellular energy production
Antosh, Stanley; Meduri Anthony 1796460*
IMidazio(4,5-B)pyrazinone inhibitors of protein kinases
Janssen Pharmaceutica 1796467*
D-methionine formulations with improved biopharmaceutical properties
Molecular Therapeutics 1796635*
Microemulsion and sub-micron emulsion process and compsns
Connetics Australia 1796636*
Targeted delivery of lidocaine and other local anaesthetics and a method for treatment of cough and tussive attacks
Corus Pharma 1796637*
Methods and kits for delivering drugs by nebulisation
Breath Limited 1796638*
Mucosal or cutaneous medicinal or hygiene system
Dow Global Technologies 1796639*
Vascular tunneller
Boston Scientific 1796640*
A novel formulation, omeprazole antacid complex-intermediate release for rapid and sustained suppression of gastric acid
Santarus 1796641*
New pharmaceuticals for the treatment of cancer
Bayer Pharmaceuticals 1796642*
Treatment of androgen-deprivation induced osteoporosis
GTX 1796643*
Drug delivery from embolic agents
Biocompatibles UK 1796644*
Agglomeration of sterol particles having a particular size
Cargill Inc 1796645*
Cosmetic neurotoxin compsn comprising a botulinum toxin component and methods
Allergan 1796646*
Stable pegylated interferon formulation
Schering 1796647*
Flavoured gelatin capsule and method of producing said action
Capsuline 1796648*
Nanotransport system having a dendritic architecture
Universitaet Dortmund 1796649*
Delivery vehicle containing nanoparticles
NanoDel Technologies 1796650*
Transdermal drug delivery device with translucent protective film
£M Innovative Properties 1796651*
Stabilisation of alum-adjuvanted immunologically active agents
Alza Corp 1796652*
Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
Actelion Pharmaceuticals 1796653*
Skin cooling compsns
Kimberley-Clark Worldwide 1796654*
Use of modulators of a novel form of muscle selective calcineurin interacting protein (MCIP-1-38) as a treatment for cardiovascular diseases
Myogen 1796655*
Compsn for inhibiting or preventing the formation of a biofilm
Oystershell 1796656*
N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
Janssen Pharmaceutica 1796657*
Dopaminergic mimetics
Ketocytonyx 1796658*
Silver dihydrogen citrate compsns
Pure Bioscience 1796659*
Use of tellurium compounds for inhibition of interleukin-converting enzyme
BioMAS 1796660*
Large-scale manufacturing process for the production of pharmaceutical compsns
Naryx Pharma 1796661*
Inhibition of viruses using RNAse H inhibitors
The Government of the United States of America as represented by the Secretary, Department of Health and Human Services 1796662*
Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
Athersys 1796663*
Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
Janssen Pharmaceutica 1796664*
Compounds for the treatment of dyslipidaemia and other lipid disorders
Merck 1796665*
Methods and compsns for the treatment of hyperlipidaemia
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences 1796666*
Mescarinic receptor antagonists
Ranbaxy Laboratories 1796667*
Aqueous pharmaceutical preparation comprising roflumilast
Altana Pharma 1796668*
Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
Merck 1796669*
Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
Chatham Biotec 1796670*
Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
Merck 1796671*
Cancer combination therapy comprising AZD2171 and IMATINIB
AstraZeneca 1796672*
Novel pyrimidine compounds, process for the preparation and compsns containing them
Reddy US Therapeutics 1796673*
5-phenoxyalkoxypsoralens and methods for selected inhibition of the voltage gated KV1.3 potassium channel
The Regents of the University of California 1796674*
Compsns and methods for treating ophthalmic diseases
Merck 1796675*
Transdermal administration of phycotoxins
Phytotox 1796676*
Method for activating TRPV4 channel receptors by agonists
SmithKline Beecham 1796677*
Carboxamide spirolactam CGRP receptor antagonists
Merck 1796678*
Ciclesonide and NYK inhibitor combination and methods of use thereof
Altana Pharma 1796679*
Methods of treating symptoms of multiple sclerosis using vitamin D and related compounds
Teva Pharmaceutical Industries 1796680*
Compounds for inhibiting copper-containing amine oxidases and uses thereof
Genmedica Therapeutics 1796681*
Method and compsn for treating patients undergoing kidney dialysis
Bionumerik Pharmaceuticals 1796682*
Methods and compsns for the administration of calcium chelators, bisphosphonases and/or citrate compounds and their pharmaceutical uses
Nanobar Life Sciences 1796683*
Vitamin B6 related compounds and methods for recovery from trauma
Medicure International 1796684*
Pyridoxal-5"-phosphate and related compounds in combination with therapeutic cardiovascular compounds for treating angina
Medicure International 1796685*
Emmprin antagonists and uses thereof
Centocor; Johnson & Johnson Research Pty 1796686*
Combination therapy for controlled carbohydrate digestion
Elixir Pharmaceuticals 1796687*
Pancreatic acner treatment using Na+/K+ ATPase inhibitors
Bionaut Pharmaceuticals 1796688*
Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin
British Columbia Cancer Agency 1796689*
Cartilage filling device
Cartilix 1796690*
Inorganic selenium for treatment of cancer
Velacor Therapeutics 1796691*
Trace elements
Warburton Technology 1796692*
Implantable tissue compsns and method
Pathak, Chandrashekhar; Thigle, Sanjay 1796693*
Methods to enhance haemodynamic stability using oxygen carrying compsns
Sangart 1796694*
Pharmaceutical agents comprising blood components <10 KDa and their use for prophylaxis and treatment of defects of the immune system
Salama, Zoser 1796695*
Compounds, compsns, formulations and process for preparation thereof and method of treatment and management of acidity and related disorders
Savangikar, Chitra; Savamgikar, Vasant 1796696*
A compsn having immunoregulating activities comprising lactobacillus pentosus
Suntory 1796697*
Strain of Lactobacillus acidophilus having analgesic properties in the gastrointestinal system
Danisco 1796698*
Early childhood infection with human herpes virus type 6 (HHV-6) as a protection against the development of IGE sensitisation, atopic disease and allergy in young children
Forskapatent i Syd 1796699*
Eukaryotic based synergistic formulation for gastro-intestinal disorders
Bharat Biotech International 1796700*
Compnsns for anti-obesity, health-restorative and health-promotional benefits
Natreon 1796701*
Use of lavender oil for prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress
Dr Wilmar Schwabe 1796702*
Carrier-free compsn for the treatment of onchomychosis
Michigan State University 1796703*
Compsn for suppressing cyclooxygenase and/or 5-lipoxygenase
Unigen 1796704*
Process for making tea extracts
Unilever 1796705*
Process for making tea extracts
Unilever 1796706*